Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), sold 60,000 shares at $142.05 ($8.5M) on 2020-05-15, disclosed to the SEC on 2020-05-15.
Open-market sale of $8.5M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.12 | 25,327 | $3.6M | 42.2% |
| 2 | $141.12 | 25,327 | $3.6M | 42.2% |
| 3 | $142.05 | 4,673 | $664K | 7.8% |
| 4 | $142.05 | 4,673 | $664K | 7.8% |
| Total | $141.26 avg | 60,000 | $8.5M | 100% |
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |